Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Doctor analysing patient brain scan results

The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s.

Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition.

The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development.

Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together.

“This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”

To read more on this topic click here.

Acupuncture may alleviate Parkinson’s symptoms

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Online video campaign ‘gives life’ to powerful Parkinson’s stories

Campaign calling for inspiring video testimonials from patients

Advances

VIDEO: Directional deep brain stimulation: novel treatment options for all Parkinson’s patients

Technological advancements offer enhanced therapy outcomes

Helping others with Parkinson’s ‘filled the gap in my life’

We talk to the founder of Parkinson’s EQUIP

Musical therapy study to receive $20 million in funding

The National Institutes of Health (NIH) is donating US $20 million to a medical trial researching the effects of musical therapy on brain conditions, including Parkinson’s. The trial will be carried out by the Sound Health initiative, a joint partnership between the NIH and The John F Kennedy Center for the Performing Arts. The initiative was created to expand current knowledge of how listening, performing and creating music could be harnessed for health and wellness. Francis S. Collins, director of the NIH, said: “We know that the beat of a metronome can steady the gait of someone with Parkinson’s disease, for example, but we don’t fully understand how that happens. “If we can pinpoint in the brain how music therapy works through the use of imaging and biomarkers, the hope is that we can improve its effectiveness and apply it more broadly to improve the lives of millions of people.”

Researchers develop automated system to diagnose Parkinson’s

In an international study, researchers from the US, Germany and Austria have used a non-invasive MRI method to develop an automated system that can diagnose Parkinson’s. As part of the study – published in medical journal ‘The Lancet Digital Health’ – researchers worked with 1,002 patients and used an imaging method that measures how water molecules diffuse in the brain. This helped them to identify where neurodegeneration is occurring. Researchers hope this will help improve the accuracy of early Parkinson’s diagnoses – which they estimate to be around 58%. Dr David Vaillancourt, who led the study, said: “Our method may help to reduce the number of misdiagnosed cases in the future. Since these diseases require unique treatment plans and different medications, and clinical trials testing new medications require the correct diagnosis, getting it right is important for patient care.”

MJFF announces $10 million competition for Parkinson’s

The Michael J Fox Foundation has launched the ‘Ken Griffin Alpha-synuclein Imaging Competition’ – a US $10 million programme aiming to develop a game-changing tool for Parkinson’s research. As part of the competition, participating teams will compete in a scientific race to build a device that is able to identify alpha-synuclein – a protein closely associated with Parkinson’s. Although almost everyone diagnosed with Parkinson’s has clumps of alpha-synuclein in the brain, these are currently only visible when analysing tissue during autopsies. The competition is named after Ken Griffin, CEO of US investment firm Citadel who has given US $7.5 million funding to the programme. Griffin – whose father has Parkinson’s – said: “If we have the imaging capability to observe the pathology that arises from protein-misfolding in real time, and understand how drugs are impacting people in real time, that would be a major advance.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Online video campaign ‘gives life’ to powerful Parkinson’s stories

sponsored article

Advances

VIDEO: Directional deep brain stimulation: novel treatment options for all Parkinson’s patients

Interviews

Helping others with Parkinson’s ‘filled the gap in my life’

Musical therapy study to receive $20 million in funding

Researchers develop automated system to diagnose Parkinson’s

MJFF announces $10 million competition for Parkinson’s

{title}

Subscribe

Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Online video campaign ‘gives life’ to powerful Parkinson’s stories

sponsored article

Advances

VIDEO: Directional deep brain stimulation: novel treatment options for all Parkinson’s patients

Interviews

Helping others with Parkinson’s ‘filled the gap in my life’

Musical therapy study to receive $20 million in funding

Researchers develop automated system to diagnose Parkinson’s

MJFF announces $10 million competition for Parkinson’s

{title}

Subscribe

Sign in